Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives

Weigang Huang1, Dechen Jiang, Xiaoyang Wang

  • 1Division of Medicinal Chemistry and Natural Products, University of North Carolina, Chapel Hill, NC 27599, USA.

Insights

Researchers developed novel fluorescent probes to measure phosphatidylinositol 3-kinase (PI3K) activity. These tools aid in cancer diagnostics and therapeutic development by enabling precise measurement of PI3K enzymatic activity in cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Phosphatidylinositol 3-kinase (PI3K) signaling is crucial for cell functions like differentiation and migration.
  • Aberrant PI3K activity, indicated by mutations and overexpression, is linked to cancer development.
  • Targeting PI3K is a promising cancer therapy strategy, necessitating accurate activity measurement.

Purpose of the Study:

  • To develop and characterize novel fluorescent reporters for direct measurement of cellular PI3K activity.
  • To assess the utility of these reporters in evaluating PI3K inhibitors for cancer therapy.
  • To establish a foundation for using PI3K activity as a diagnostic and therapeutic marker.

Main Methods:

  • Synthesis and characterization of two fluorescent phosphatidylinositol 4,5-bisphosphate (PIP2) derivatives as PI3K substrates.
  • Separation of PI3K enzymatic products using thin-layer chromatography (TLC) and capillary electrophoresis (CE).
  • Detection of fluorescent reporters and products with high sensitivity; measurement of probe kinetics and biophysical properties.

Main Results:

  • The fluorescent PIP2 derivatives effectively serve as substrates for PI3K enzymatic assays.
  • Efficient separation and sensitive fluorescence detection of PI3K reaction products were achieved.
  • Both probes demonstrated suitability for PI3K inhibitor characterization, with distinct properties for varied applications.

Conclusions:

  • The developed fluorescent probes provide a robust method for measuring cellular PI3K activity.
  • These tools can facilitate the development of PI3K-targeted cancer therapies and diagnostics.
  • Systematic measurement of PI3K activity may lead to molecular 'fingerprints' for personalized medicine.